NCT02340169View on ClinicalTrials.gov

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

January 23, 2015

Primary Completion Date

November 22, 2019

Study Completion Date

November 22, 2021

Conditions

Plaque Psoriasis

Interventions

DRUG

Topicort® (desoximetasone) Topical Spray, 0.25%

Topicort® (desoximetasone) Topical Spray, 0.25% applied to affected areas twice a day for 28 days

Trial Locations (1)

10532

Taro Pharmaceuticals USA Inc., Hawthorne

All Listed Sponsors

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02340169 - Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis | Biotech Hunter | Biotech Hunter